THORENS 25 000 I.U. /2.5 ml oral solution *
Pharmacy Only: Prescription

Updated on 23 January 2023

File name

63ce707a8c0ca.pdf

Reasons for updating

  • Document format updated

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 01 December 2020

File name

05-2_1606826151.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 16 September 2020

File name

05-2_1600260707.pdf

Reasons for updating

  • Change to section 6 - date of revision

Updated on 16 September 2020

File name

05-3_1600257963.pdf

Reasons for updating

  • Change to section 6 - date of revision

Updated on 16 September 2020

File name

05-3_1600257963.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Updated on 06 June 2019

File name

Thorens 25000_1559808973.pdf

Reasons for updating

  • Change to section 6 - date of revision
  • Removal/change of distributor

Updated on 09 October 2018

File name

ie-spc-thorens-25000_1539072530.pdf

Reasons for updating

  • Change to section 9 - Date of first authorisation/renewal of the authorisation

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Section 9 of the THORENS 25 000 I.U. /2.5ml oral solution Summary of Product Characteristics has been updated to add in the date of last renewal.

Updated on 01 August 2018

File name

Thorens 25000 PIL_1533132200.pdf

Reasons for updating

  • Change to Section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - how to report a side effect
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 01 August 2018

File name

thorens 25000 compressed_1533129723.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

.

Updated on 01 August 2018

File name

thorens 25000 compressed_1533128529.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

.

Updated on 29 June 2015

File name

PIL_16387_515.pdf

Reasons for updating

  • New PIL for new product

Updated on 29 June 2015

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)